oxidopamine has been researched along with Brain Neoplasms in 6 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ingraham, CA | 1 |
| Wertalik, L | 1 |
| Schor, NF | 1 |
| Shimizu, E | 1 |
| Hashimoto, K | 1 |
| Komatsu, N | 1 |
| Iyo, M | 1 |
| Parish, CL | 1 |
| Parisi, S | 1 |
| Persico, MG | 1 |
| Arenas, E | 1 |
| Minchiotti, G | 1 |
| Thinyane, K | 1 |
| Baier, PC | 1 |
| Schindehütte, J | 1 |
| Mansouri, A | 1 |
| Paulus, W | 1 |
| Trenkwalder, C | 1 |
| Flügge, G | 1 |
| Fuchs, E | 1 |
| Zuo, D | 1 |
| Yu, PH | 2 |
| Zuo, DM | 1 |
6 other studies available for oxidopamine and Brain Neoplasms
| Article | Year |
|---|---|
Necdin and neurotrophin receptors: interactors of relevance for neuronal resistance to oxidant stress.
Topics: Adrenergic Agents; Animals; Brain Neoplasms; Cell Line, Tumor; Gene Knockdown Techniques; Humans; Mi | 2011 |
Roles of endogenous glutathione levels on 6-hydroxydopamine-induced apoptotic neuronal cell death in human neuroblastoma SK-N-SH cells.
Topics: Acetylcysteine; Apoptosis; Benzimidazoles; Brain Neoplasms; Buthionine Sulfoximine; Cystine; DNA Fra | 2002 |
Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease.
Topics: Animals; Brain; Brain Neoplasms; Cell Differentiation; Dopamine; Embryo, Mammalian; Epidermal Growth | 2005 |
Fate of pre-differentiated mouse embryonic stem cells transplanted in unilaterally 6-hydroxydopamine lesioned rats: histological characterization of the grafted cells.
Topics: Animals; Biomarkers; Brain Neoplasms; Cell Count; Cell Differentiation; Cell Lineage; Cell Prolifera | 2005 |
Increase of survival of dopaminergic neuroblastoma in co-cultures with C-6 glioma by R-(-)-deprenyl.
Topics: Brain Neoplasms; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Glioma; Humans; Neurobla | 1995 |
Enhanced tolerance of neuroblastoma cells towards the neurotoxin 6-hydroxydopamine following specific cell-cell interaction with primary astrocytes.
Topics: Animals; Antibodies; Astrocytes; Brain Neoplasms; Cell Adhesion; Cell Communication; Cell Survival; | 1997 |